Phase I factorial study of temozolomide plus memantine, mefloquine, and metformin as post-radiation adjuvant therapy for newly diagnosed glioblastoma.

被引：0
|
作者：
Maraka, Stefania
Groves, Morris D.
Mammoser, Aaron Gerald
Melguizo-Gavilanes, Isaac
Conrad, Charles A.
Tremont-Lukats, Ivo
Loghin, Monica Elena
O'Brien, Barbara Jane
Puduvalli, Vinay K.
Sulman, Erik P.
Hess, Kenneth R.
Aldape, Kenneth D.
Gilbert, Mark R.
De Groot, John Frederick
Yung, W. K. Alfred
Penas-Prado, Marta
机构：
[1] Univ Texas MD Anderson Canc Ctr, Neurooncol Dept, Houston, TX USA
[2] LSU Hlth Sci Ctr, Dept Neurosurg, New Orleans, LA USA
[3] Aurora Canc Care Neurooncol, Milwaukee, WI USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[5] Houston Methodist Hosp, Neurooncol, Neurol, Houston, TX USA
[6] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
[7] Natl Canc Inst, Ctr Canc Res, Bethesda, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.2044
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2044
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
    Kortmann, Rolf-Dieter
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (10) : 670 - 671
  • [22] A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma
    Gilbert, Mark R.
    Gonzalez, Javier
    Hunter, Kathy
    Hess, Kenneth
    Giglio, Pierre
    Chang, Eric
    Puduvalli, Vinay
    Groves, Morris D.
    Colman, Howard
    Conrad, Charles
    Levin, Victor
    Woo, Shaio
    Mahajan, Anita
    de Groot, John
    Yung, W. K. Alfred
    NEURO-ONCOLOGY, 2010, 12 (11) : 1167 - 1172
  • [23] Phase 1b/2 study of pexidartinib (PEX) in combination with radiation therapy (XRT) and temozolomide (TMZ) in newly diagnosed glioblastoma.
    Colman, Howard
    Raizer, Jeffrey J.
    Walbert, Tobias
    Plotkin, Scott Randall
    Chamberlain, Marc C.
    Wong, Eric T.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [24] Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
    Lai, Albert
    Tran, Anh
    Nghiemphu, Phioanh L.
    Pope, Whitney B.
    Solis, Orestes E.
    Selch, Michael
    Filka, Emese
    Yong, William H.
    Mischel, Paul S.
    Liau, Linda M.
    Phuphanich, Surasak
    Black, Keith
    Peak, Scott
    Green, Richard M.
    Spier, Cynthia E.
    Kolevska, Tatjana
    Polikoff, Jonathan
    Fehrenbacher, Louis
    Elashoff, Robert
    Cloughesy, Timothy
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (02) : 142 - 148
  • [25] Metformin with Temozolomide for Newly Diagnosed Glioblastoma: Results of Phase I Study and a Brief Review of Relevant Studies
    Ohno, Makoto
    Kitanaka, Chifumi
    Miyakita, Yasuji
    Tanaka, Shota
    Sonoda, Yukihiko
    Mishima, Kazuhiko
    Ishikawa, Eiichi
    Takahashi, Masamichi
    Yanagisawa, Shunsuke
    Ohashi, Ken
    Nagane, Motoo
    Narita, Yoshitaka
    CANCERS, 2022, 14 (17)
  • [26] Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: A phase I study
    Butowski, Nicholas
    Chang, Susan M.
    Lamborn, Kathleen R.
    Polley, Mei Yin
    Parvataneni, R.
    Hristova-Kazmierski, Maria
    Musib, Luna
    Nicol, Steven J.
    Thornton, Donald E.
    Prados, Michael D.
    NEURO-ONCOLOGY, 2010, 12 (06) : 608 - 613
  • [27] Phase I/II study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme (GBM) or gliosarcoma
    Butowski, N. A.
    Lamborn, K.
    Chang, S.
    Thornton, D.
    DeBoer, R.
    Page, M.
    Rabbitt, J.
    Parvanateni, R.
    Kivett, V.
    Nicol, S.
    Prados, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] PHASE I/II TRIAL OF RADIATION THERAPY, TEMOZOLOMIDE AND PEMBROLIZUMAB FOLLOWED BY TEMOZOLOMIDE AND PEMBROLIZUMAB IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Dixit, Karan
    Kumthekar, Priya
    Kruser, Timothy
    Bloch, Orin
    Chandler, James
    Tate, Matthew
    Raizer, Jeffrey
    NEURO-ONCOLOGY, 2016, 18 : 19 - 19
  • [29] PHASE I STUDY OF VANDETANIB WITH RADIOTHERAPY AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA
    Drappatz, Jan
    Norden, Andrew D.
    Wong, Eric T.
    Doherty, Lisa M.
    LaFrankie, Debra C.
    Ciampa, Abigail
    Kesari, Santosh
    Sceppa, Christine
    Gerard, Mary
    Phan, Phuong
    Schiff, David
    Batchelor, Tracy T.
    Ligon, Keith L.
    Young, Geoffrey
    Muzikansky, Alona
    Weiss, Stephanie E.
    Wen, Patrick Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (01): : 85 - 90
  • [30] Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide
    Stupp, R
    Dietrich, PY
    Kraljevic, SO
    Pica, A
    Maillard, I
    Maeder, P
    Meuli, R
    Janzer, R
    Pizzolato, G
    Miralbell, R
    Porchet, F
    Regli, L
    de Tribolet, N
    Mirimanoff, RO
    Leyvraz, S
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) : 1375 - 1382
12345